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T-cell regulation: Thy-1 — hiding in full view
Nigel Killeen
Thy-1 is a highly abundant glycoprotein on the surface
of thymocytes and neurons. A null mutation in the gene
encoding Thy-1 deregulates T-cell receptor signaling and
causes abnormal thymocyte development; does this
mean that Thy-1 has a signaling function?
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Cellular responses have to be regulated not only
positively, so that they are activated in response to
appropriate stimuli, but also negatively, to ensure that the
response has appropriate magnitude and time course.
Such negative regulation may be especially important in
the case of dynamic multicellular systems such as the
immune system, which is characterized by life-long self-
renewal, latent hyperproliferative capability and the
potential for fatal autoaggression. Recent years have seen
considerable progress in uncovering some of the molecular
mediators that contribute to the negative regulation of the
immune system. For instance, studies on inhibitory
receptors expressed by natural killer cells have revealed
the crucial roles that they play in limiting inappropriate
cytotoxicity [1].
Negative regulatory functions have also been ascribed to a
variety of molecules expressed by B and T lymphocytes.
For B cells, these include the cell surface glycoprotein
CD22, the intracellular Src-related tyrosine kinase Lyn,
and the protein tyrosine phosphatase Shp-1 [2]. The
inhibitory actions of these molecules impinge on the sensi-
tivity of signaling through the B-cell antigen receptor, and
thereby influence B-cell responses and tolerance. For T
cells, the CTLA-4 glycoprotein mediates an essential neg-
ative regulatory function, as made dramatically clear by the
fatal lymphoproliferative disorder of CTLA-4 null mutant
mice [3]. Several other studies with knockout mice have
suggested that a number of cell surface molecules found on
T cells may have negative regulatory functions [4–8]. One
of these molecules is the ever-enigmatic Thy-1 (CD90).
Since Thy-1 was first identified serologically in the 1960s
[9], it has been the subject of research that has led to
several fundamental discoveries. Firstly, antisera that were
specific for Thy-1 were the first reagents that could
discriminate T cells from B cells [10], an attribute of
profound experimental significance that needs little
elaboration. Secondly, structural studies on Thy-1 in the
1970s [11] helped to establish the foundation of the
immunoglobulin superfamily, the known members of
which now comprise approximately one third of all known
leukocyte membrane proteins [12]. Thirdly, the structural
analysis of Thy-1 also led to the first biochemical descrip-
tion of a vertebrate glycosyl phosphatidylinositol (GPI)
anchor [13,14]. Such anchors are now known to provide a
general mechanism for tethering a wide range of surface
proteins to the plasma membrane. Thus, as a subject of
experimentation, Thy-1 has proven to be remarkably
rewarding over the course of three decades. Paradoxically,
despite this lengthy and rich history, Thy-1’s own func-
tion has remained elusive.
Thy-1 is a small heavily glycosylated glycoprotein made
up of a single immmunoglobulin-related domain, to which
three N-linked carbohydrates are attached. Although its
expression pattern shows some variability between
species, Thy-1 is found on T cells, thymocytes and
neurons in mice. In the thymus, Thy-1 is probably the
most abundant glycoprotein on the surface of thymocytes
and is present at about a million molecules per cell
(compare this to ~15,000 molecules of CD4 per cell).
Indeed, by one calculation, Thy-1 may cover 10–20% of
the thymocyte surface area [12]. Thus, Thy-1 is perhaps
well described as a major architectural component of the
thymocyte surface, a distinction that could be intimately
tied to its normal function.
As a possible clue to the function of Thy-1, considerable
interest has surrounded the signaling effects of Thy-1-spe-
cific antibodies [15]. In large part, this is because of the
apparent contradiction of transmembrane signaling by a
molecule that does not pass through the inner leaflet of the
plasma membrane. Interestingly, GPI-linked molecules
such as Thy-1 cosegregate with protein tyrosine kinases in
detergent-insoluble complexes of cellular lysates [16]. This
cosegregation may reflect the regulated (perhaps ligand-
directed) formation of physiologic associations that would
allow Thy-1 to transmit signals. However, the natural for-
mation of such associations — in the absence of exoge-
nously applied antibody — has yet to be demonstrated,
leaving in doubt the potential relevance of the antibody-
dependent signaling effects. Furthermore, no ligand for
Thy-1 has yet been defined in firm molecular terms.
To pursue the function of Thy-1 further, null mutant
mice bearing a disruption of the Thy-1 gene were recently
generated. The initial description of these animals
focused entirely on the nature of a unique neuronal defect
[17]. Specifically, the loss of Thy-1 correlated with
regional impairment of long-term potentiation in the
dentate gyrus of the hippocampus. Despite this defect,
Thy-1-deficient brains were anatomically normal, and the
mice showed no detectable problems with spatial learning.
A subsequent report on the immunologic phenotype of
the Thy-1 mutant mice was published recently in Current
Biology [7]. At first glance, the Thy-1 mutation appears to
have an unexpectedly modest effect on T cells; however,
a careful examination of the mutant thymocytes uncov-
ered evidence of a signaling defect that is curiously remi-
niscent of observations made on several null mutant
animals lacking other T-cell surface molecules [4–6,8].
The essence of the defect in Thy-1-null thymocytes
appears not to be inefficient signaling, but an enhanced
response to mitogenic stimulation through the T-cell
antigen receptor. This is manifest at the level of tyrosine
phosphorylation, calcium mobilization and proliferation.
Interestingly, there are developmental abnormalities that
accompany the signaling phenotype and that could well
be a direct consequence of it. Specifically, there is
impaired development of mature thymocytes expressing
the CD8 coreceptor, particularly in Thy-1 mutants that
also carry a T-cell receptor transgene. A kinetic analysis
revealed further evidence for abnormal development,
apparent as a reduced rate of production of mature ‘single
positive’ cells — CD4 or CD8 T cells — and a possible
decreased survival of their ‘double-positive’ (CD4, CD8)
precursors. Finally, these same double-positive thymo-
cytes appear to be enriched for cells that retain expression
of RAG-1 — required for the joining of germ-line gene
segments to form a productive T-cell receptor gene — a
property indicative of an atypical immature status and
consistent with the view that the absence of Thy-1 causes
a developmental barrier. 
Enhanced signaling through the T-cell receptor is
perhaps not an obvious cause of inefficient development.
One possible explanation for the apparent correlation is
that the phenotype may in fact be one of exaggerated
negative selection. In this scenario, more thymocytes
would be deleted when Thy-1 is absent, because strong
T-cell receptor signaling is likely to increase the fraction
of cells that would undergo apoptosis. Interestingly,
CD5-null mice exhibit a similar signaling defect and have
developmental problems that are made particularly clear
when the mutant mice also carry a T-cell receptor trans-
gene [4]. But while the Thy-1 mutation causes impaired
development of T-cell receptor transgenic CD8 T cells,
the CD5 mutation has the opposite effect. The basis for
this apparent discrepancy is unclear, but it could reflect
quantitative differences in the way that the Thy-1 and
CD5 mutations affect T-cell receptor signaling. Specifi-
cally, the lack of CD5 could result in a weaker derepres-
sion of signaling than the lack of Thy-1, so that the
selection of cells expressing the transgenic T-cell recep-
tor is potentiated by the former, whereas apoptosis results
from the latter. 
Alternatively, rather than the loss of negative regulation,
the developmental barrier in the Thy-1-null thymus could
be due to the absence of a positive function of Thy-1 that
is necessary for efficient development. This last idea
prompts further consideration of how the absence of Thy-1
might influence T-cell receptor signaling and affect thy-
mocyte development. As one possible approach to this, it
may be useful to consider the related hyper-responsive
phenotypes caused by deficiencies of several other cell
surface molecules (see Figure 1).
Of the five molecules shown in Figure 1, the negative
regulatory effect conferred by CD43 may be the most
straightforward to understand. This molecule is highly
expressed on T cells and thymocytes, and it is also a scaf-
fold for extensive negative charge in the form of O-linked
glycosylation and sialylation [12]. As a consequence of its
abundance and negative charge, CD43 is well equipped to
interfere with the formation of intercellular conjugates.
Consistent with this, the absence of CD43 causes sponta-
neous aggregation of T cells, presumably because of a loss
of electrostatic repulsion between the cells [8,18]. Thus,
an enhanced capacity to form conjugates could well result
in more frequent or productive engagements of T-cell
receptors and costimulatory molecules; this in turn could
account in large part for the observed signaling phenotype
exhibited by CD43-null T cells.
CD5 and CD81, in contrast, may be expected to have a
more direct impact on antigen receptor signaling. These
two molecules can be coimmunoprecipitated with key
signal transduction modules found on the surface of T
cells and B cells, respectively. CD5 associates with com-
ponents of the T-cell antigen receptor [19], and CD81 is
linked to the CD19/CD21 complex [20]. Although the
significance of the CD5–T-cell receptor association is
uncertain, stimulation of the T-cell receptor leads to the
rapid tyrosine phosphorylation of an ITAM-like motif in
the cytoplasmic tail of CD5 [21]. Perhaps more signifi-
cantly, there is one report of an association between CD5
and SHP-1 [22], and another showing a similar associa-
tion with PI-3 kinase [23], both of which are intracellular
molecules with negative regulatory functions. The
CD81/CD19/CD21 complex provides a potent costimu-
latory function for B-cell activation and it too undergoes
rapid phosphorylation after surface immunoglobulin
crosslinking [20]. Interestingly, CD81 was first identified
with a monoclonal antibody that interfered with the pro-
liferation of lymphoblastoid cells [24]. Thus, for both
CD5 and CD81, there is an existing framework of signal-
ing data within which to consider possible mechanisms
of negative regulation. 
Dispatch R775
R776 Current Biology, Vol 7 No 12
Thy-1 and Ly-6A are both GPI-linked structures. As men-
tioned above, this endows them with in vitro signaling
properties that may have physiologic significance. Such
signaling properties could be involved in negative regula-
tion of antigen receptor signaling, perhaps through the for-
mation of plasma membrane microdomains that would
sequester signaling molecules such as protein tyrosine
kinases. However, it is also possible that the absence of
Thy-1 may have a more indirect effect on the efficiency of
signaling, along the lines of the mechanism proposed
above for CD43. 
As Thy-1 normally occupies a large fraction of the
thymocyte surface, its absence should be expected to have
a profound effect on the physical appearance and
behaviour of the cell surface. This may be apparent either
in the way that key molecules are distributed on the
surface of thymocytes, or alternatively in the way that
thymocytes interact with other cells such as thymic
epithelial cells or medullary macrophages. Interestingly,
electron microscopy of the Thy-1-null thymus revealed
striking evidence of atypical contacts between cells, con-
sistent with the idea that intercellular interactions are
abnormal because of the mutation. Exactly how such
abnormal intercellular interactions would translate into
augmented responses to T-cell receptor stimulation is not
immediately apparent. 
A ligand for Thy-1, if it exists, could allow for firm conju-
gation with the thymic stroma and may thereby facilitate
the transduction of signals that would influence the
responsiveness of the T-cell receptor. A precedent for this
is well established in the form of interactions between
CD4 and class II major histocompatibility complex mole-
cules that downregulate T-cell receptor expression on
double-positive thymocytes [25]. Alternatively, the Thy-
1-depleted surface may allow for more effective clustering
of T-cell receptors, perhaps because they are localized in a
different fashion on the cell surface or because there is
less material — like Thy-1-attached oligosaccharides — to
impede their aggregation. Whatever its precise molecular
basis, the key issue here may be the highly abundant
expression of Thy-1, which could indirectly affect T-cell
receptor signal transduction in a way that does not neces-
sarily involve a unique signaling role for Thy-1 itself.
Clearly, the function of Thy-1 still remains elusive,
despite the interesting phenotype of the Thy-1 knockout
mouse. An important challenge for the future may lie in
understanding precisely how Thy-1 influences the physi-
cal characteristics of the cell surface and the exact nature
of its effect on T-cell receptor signaling. In this regard,
Thy-1-null thymocytes may be especially useful experi-
mentally and one cannot help but suspect that lessons of
fundamental cell biological importance may still be forth-
coming from this unusual molecule.
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